drugset / Trial / NCT05872789

Impact of Diazepam 1% Oral Gel Efficacy in Burning Mouth Syndrome

NCT05872789

Completed 40 enrolled University of Catania
RandomizedParallel-groupDouble-blindTreatment

Summary

Burning mouth syndrome (BMS) is a syndrome characterized by burning and persistent oral pain, ranging from mild to intense, in the absence of organic disorders of the oral cavity and with a major impact on the quality of life of the sufferer. Although several etiological theories have been proposed to explain BMS, none has been universally accepted to date, and its origin remains unclear. Currently, several scientific evidences would suggest that underlying BMS would be alterations in certain neuropathic mechanisms. The purpose of the study is to evaluate the efficacy of Diazepam 1% oral gel in the treatment of burning mouth syndrome.

Timeline

Start
2020-05-02
Primary completion
2023-09-12
Completion
2023-10-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Diazepam Small molecule 1 % Topical